Etta Biotech 「invites」 you to meet Beijing · 2019.1.21-22
The 9th Asia Pharma R&D Leaders, as one of the top strategic summits with the theme of R&D in the pharmaceutical industry in Asia, is about to open at Four Points By Sheraton Beijing, Haidian. By keynote speech, roundtable discussion, company showcase, exhibition booth and 1-2-1 meeting system, this two-day event will share insightful ideas from Asian pharmaceutical leaders, as well as provide fat chances for you to find potential projects and partners. Etta Biotech Co., Ltd. will bring Etta Cell Electroporator X-Porator H1 PLUS and Etta Flow Electroporator X-Porator F1 to the ceremony ！
2019-01-17 18:57
Within two months, we have received three orders of Etta flow electroporator X-Porator F1!
Etta flow electroporator X-Porator F1 is the result of four years of painstaking R&D and manufacturing of Etta Biotech. Less than two months after its launch, it has received orders from three antibody drug companies in Suzhou, Beijing and Hangzhou, showing users' affirmation of its performance! The main performance of Etta flow electroporator X-Porator F1 is the transient transformation of a large number of engineered cells to produce antibody proteins, which has a great application prospect in the field of antibody drug development and production. In the user trial, the expression level of diplasmid system hIgG in CHO cells was 2-5 times higher than that in chemical transfection from one user. The expression level of single-chain anti-somatic particles with low expression by chemical transfection in CHO cells was increased by more than 40 times from another user.
2018-12-13 13:40
On November 19, 2018, Etta biotech Co., Ltd. (Hereinafter referred to as "Etta Biotech") and Zhongshan Beisen Medical Fund officially signed an investment agreement, announcing the successful completion of the A-round financing of tens of millions of RMB. Beisen Medical Fund is the sole investor in this round of financing. It is Etta’s investment obtained from another well-known investment institution in the industry, after the famous angel investor Li Jing and Jiangsu Qianrong Financing Capital.
2018-11-19 11:36
Follow us
Free newsletter sign up
Sign up to our free newsletter and get the latest
news sent direct to your inbox
Etta Biotech Co., Ltd. Copyright © 2022-2025 All Rights Reserved.
Etta Biotech Co., Ltd. Copyright
© 2014-2022 All Rights Reserved
苏ICP备19051029号